Literature DB >> 24269279

MKP-1 signaling events are required for early osteoclastogenesis in lineage defined progenitor populations by disrupting RANKL-induced NFATc1 nuclear translocation.

Michael S Valerio1, Bethany A Herbert1, Alfred C Griffin1, Zhuang Wan2, Elizabeth G Hill3, Keith L Kirkwood4.   

Abstract

Cytokine-directed osteoclastogenesis is initiated in response to macrophage colony stimulating factor (M-CSF) and receptor activator of NF-κB ligand (RANKL) to drive formation of osteoclasts (OC), large bone resorptive cells of hematopoietic origin. RANKL-induced signaling activates the MAPK pathways, which initiates nuclear translocation of the master regulator of osteoclast formation, transcription factor NFATc1. Proper control over these signaling events is essential to normal OC formation response to stimuli. MAPK phosphatase 1 (MKP-1), a serine and tyrosine phosphatase encoded by the gene Dusp1, functions to dephosphorylate and subsequently inactivate MAPK (p38 and JNK) signaling essential in osteoclastogenesis. Here, we explored the role of MKP-1 during RANKL-driven osteoclastogenesis from defined (B220/CD45(-)GR1(-)CD11b(lo/-)CD115(+)) OC progenitor (dOCP) populations using WT and Dusp1(-/-) global knockout mice. Sorted cells were driven to OC by M-CSF pre-treatment followed by RANKL stimulation for 3days. OC formation and qPCR products were analyzed for maturation. Results indicate that Dusp1(-/-) dOCP form less numerous, significantly smaller and less functional OC compared to WT controls. These data were corroborated by mRNA expression of the key OC genes, Nfatc1 and Tm7sf4 (DC-STAMP), which were significantly reduced in early osteoclastogenesis in OC progenitor from Dusp1(-/-) mice. Intriguingly, our data reveals that MKP-1 may positively control OC formation in response to RANKL by regulating NFATc1 nuclear translocation. Collectively, this report supports the idea that MKP-1 signaling is essential in early osteoclastogenesis in response to RANKL-induced signaling.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cytokine; MAPK phosphatase; Osteoclastogenesis; Progenitors; RANKL

Mesh:

Substances:

Year:  2013        PMID: 24269279      PMCID: PMC3945035          DOI: 10.1016/j.bone.2013.11.012

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  38 in total

Review 1.  Do RANKL inhibitors (denosumab) affect inflammation and immunity?

Authors:  S Ferrari-Lacraz; S Ferrari
Journal:  Osteoporos Int       Date:  2010-06-23       Impact factor: 4.507

2.  Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta.

Authors:  K Horiuchi; N Amizuka; S Takeshita; H Takamatsu; M Katsuura; H Ozawa; Y Toyama; L F Bonewald; A Kudo
Journal:  J Bone Miner Res       Date:  1999-07       Impact factor: 6.741

3.  Identification of multiple osteoclast precursor populations in murine bone marrow.

Authors:  Claire Jacquin; Diane E Gran; Sun Kyeong Lee; Joseph A Lorenzo; Hector L Aguila
Journal:  J Bone Miner Res       Date:  2005-10-18       Impact factor: 6.741

4.  Anti-inflammatory effect of MAPK phosphatase-1 local gene transfer in inflammatory bone loss.

Authors:  H Yu; Q Li; B Herbert; R Zinna; K Martin; C R Junior; K L Kirkwood
Journal:  Gene Ther       Date:  2010-11-11       Impact factor: 5.250

5.  Defective T cell differentiation in the absence of Jnk1.

Authors:  C Dong; D D Yang; M Wysk; A J Whitmarsh; R J Davis; R A Flavell
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

6.  Essential role of p38 mitogen-activated protein kinase in cathepsin K gene expression during osteoclastogenesis through association of NFATc1 and PU.1.

Authors:  Masahito Matsumoto; Masakazu Kogawa; Seiki Wada; Hiroshi Takayanagi; Masafumi Tsujimoto; Shigehiro Katayama; Koji Hisatake; Yasuhisa Nogi
Journal:  J Biol Chem       Date:  2004-08-09       Impact factor: 5.157

7.  The role of Mac-1 (CD11b/CD18) in osteoclast differentiation induced by receptor activator of nuclear factor-kappaB ligand.

Authors:  Hidetaka Hayashi; Ken-ichi Nakahama; Takahiro Sato; Takehiko Tuchiya; Yasuyuki Asakawa; Toshimitu Maemura; Masanobu Tanaka; Mineto Morita; Ikuo Morita
Journal:  FEBS Lett       Date:  2008-09-04       Impact factor: 4.124

8.  MKP-1 is necessary for T cell activation and function.

Authors:  Yongliang Zhang; Joseph M Reynolds; Seon Hee Chang; Natalia Martin-Orozco; Yeonseok Chung; Roza I Nurieva; Chen Dong
Journal:  J Biol Chem       Date:  2009-09-10       Impact factor: 5.157

9.  Lipopolysaccharide suppresses RANK gene expression in macrophages by down-regulating PU.1 and MITF.

Authors:  Junko Ishii; Riko Kitazawa; Kiyoshi Mori; Kevin P McHugh; Eiichi Morii; Takeshi Kondo; Sohei Kitazawa
Journal:  J Cell Biochem       Date:  2008-10-15       Impact factor: 4.429

10.  TGF-β inducible early gene 1 regulates osteoclast differentiation and survival by mediating the NFATc1, AKT, and MEK/ERK signaling pathways.

Authors:  Muzaffer Cicek; Anne Vrabel; Catherine Sturchio; Larry Pederson; John R Hawse; Malayannan Subramaniam; Thomas C Spelsberg; Merry Jo Oursler
Journal:  PLoS One       Date:  2011-03-14       Impact factor: 3.240

View more
  10 in total

1.  Critical role of MKP-1 in lipopolysaccharide-induced osteoclast formation through CXCL1 and CXCL2.

Authors:  Michael S Valerio; Bethany A Herbert; Dimitrios S Basilakos; Courtney Browne; Hong Yu; Keith L Kirkwood
Journal:  Cytokine       Date:  2014-09-27       Impact factor: 3.861

2.  Mitogen-Activated Protein Kinase 2 Signaling Shapes Macrophage Plasticity in Aggregatibacter actinomycetemcomitans-Induced Bone Loss.

Authors:  Bethany A Herbert; Heidi M Steinkamp; Matthias Gaestel; Keith L Kirkwood
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

Review 3.  Myeloid-Derived Suppressor Cells at the Intersection of Inflammaging and Bone Fragility.

Authors:  Keith L Kirkwood; Lixia Zhang; Ramkumar Thiyagarajan; Kenneth L Seldeen; Bruce R Troen
Journal:  Immunol Invest       Date:  2018-11       Impact factor: 3.657

4.  Functionalized nanoparticles containing MKP-1 agonists reduce periodontal bone loss.

Authors:  Michael S Valerio; Frank Alexis; Keith L Kirkwood
Journal:  J Periodontol       Date:  2019-03-13       Impact factor: 6.993

5.  Sex-based differential regulation of bacterial-induced bone resorption.

Authors:  M S Valerio; D S Basilakos; J E Kirkpatrick; M Chavez; J Hathaway-Schrader; B A Herbert; K L Kirkwood
Journal:  J Periodontal Res       Date:  2016-08-11       Impact factor: 4.419

6.  Sexual Dimorphism in MAPK-Activated Protein Kinase-2 (MK2) Regulation of RANKL-Induced Osteoclastogenesis in Osteoclast Progenitor Subpopulations.

Authors:  Bethany A Herbert; Michael S Valerio; Matthias Gaestel; Keith L Kirkwood
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

Review 7.  Protein tyrosine phosphatases in skeletal development and diseases.

Authors:  Huiliang Yang; Lijun Wang; Christian Shigley; Wentian Yang
Journal:  Bone Res       Date:  2022-01-28       Impact factor: 13.567

8.  Expansion of myeloid-derived suppressor cells contributes to metabolic osteoarthritis through subchondral bone remodeling.

Authors:  Lixia Zhang; Cameron L Kirkwood; Jiho Sohn; Ashley Lau; Mary Bayers-Thering; Supinder Kour Bali; Sridhar Rachala; John M Marzo; Mark J Anders; Frank Beier; Keith L Kirkwood
Journal:  Arthritis Res Ther       Date:  2021-11-16       Impact factor: 5.156

9.  Osteoblast Lineage Cells Play an Essential Role in Periodontal Bone Loss Through Activation of Nuclear Factor-Kappa B.

Authors:  Sandra Pacios; Wenmei Xiao; Marcelo Mattos; Jason Lim; Rohinton S Tarapore; Sarah Alsadun; Bo Yu; Cun-Yu Wang; Dana T Graves
Journal:  Sci Rep       Date:  2015-12-15       Impact factor: 4.379

10.  Commensal Gut Microbiota Immunomodulatory Actions in Bone Marrow and Liver have Catabolic Effects on Skeletal Homeostasis in Health.

Authors:  Chad M Novince; Carolyn R Whittow; Johannes D Aartun; Jessica D Hathaway; Nicole Poulides; Michael B Chavez; Heidi M Steinkamp; Kaeleigh A Kirkwood; Emily Huang; Caroline Westwater; Keith L Kirkwood
Journal:  Sci Rep       Date:  2017-07-18       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.